Related Experiment Video
Updated: Jan 18, 2026

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
Cardiovascular and venous thromboembolic events in systemic sclerosis: epidemiological analysis of the Clinical
John D Pauling1,2,3, Rachel Charlton2, Laura Ross4,5
1Department of Rheumatology, North Bristol NHS Trust, Bristol, UK.
Insights
Systemic sclerosis (SSc) patients face increased risks of cardiovascular events and venous thromboembolism (VTE), both before and after diagnosis. Further research is needed to understand these thrombotic events and improve patient outcomes.
Area of Science:
- Rheumatology
- Cardiology
- Epidemiology
Background:
- Cardiovascular disease (CVD) is a primary cause of mortality in systemic sclerosis (SSc).
- Understanding the association between SSc and cardiovascular/thromboembolic events is crucial for patient management.
Purpose of the Study:
- To investigate the association between systemic sclerosis (SSc) and the occurrence of cardiovascular and thromboembolic events.
- To analyze event rates in SSc patients compared to matched non-SSc individuals.
Main Methods:
- A cohort study utilized the Clinical Practice Research Datalink (CPRD) to identify SSc cases.
- Rates of coronary arterial disease (CAD), cerebrovascular disease, peripheral artery disease (PAD), and venous thromboembolism (VTE) were compared between SSc patients and matched controls.
- Cox regression analysis adjusted for traditional cardiovascular risk factors.
Main Results:
- A higher prevalence of CAD, PAD, and VTE was observed at baseline in the SSc cohort.
- SSc patients exhibited a significantly increased risk of CAD, PAD, peripheral venous thromboses, and pulmonary embolism during follow-up (adjusted hazard ratios 1.84-3.01).
- No increased risk of cerebrovascular disease was found in SSc patients.
Conclusions:
- Systemic sclerosis is associated with an elevated risk of cardiovascular events and VTE, occurring both before and within 8 years of diagnosis.
- Further research is required to elucidate the mechanisms underlying arterial and venous thrombotic events in SSc.
- Identifying these mechanisms can lead to more targeted preventative strategies and improved outcomes for SSc patients.
Objectives:
Cardiovascular disease is a leading cause of mortality in systemic sclerosis (SSc). We investigated the association between SSc and the occurrence of both cardiovascular and thromboembolic events using the Clinical Practice Research Datalink (CPRD).
Methods:
A validated case-ascertainment strategy identified SSc patients in the CPRD. A cohort study design examined rates of coronary arterial disease (CAD), cerebrovascular disease, peripheral artery disease (PAD) and venous thromboembolism (VTE) in SSc patients matched to non-SSc comparators by age, sex and location in a 1:6 ratio. Prevalent and incident cases of SSc were analysed separately. Cox regression analysis was used to determine hazard ratios for event occurrence, adjusted for traditional cardiovascular risk factors.
Results:
We identified 877 eligible incident cases of SSc who were matched to 5262 patients without SSc (83.7% female), with a mean follow-up of 8 years. We identified a higher background prevalence of CAD, PAD and VTE at baseline (pre-dating diagnosis) in the SSc cohort. There was a significantly increased risk of CAD, PAD, peripheral venous thromboses and pulmonary embolism during follow-up in SSc compared with the non-SSc group (adjusted hazard ratios between 1.84-3.01), particularly amongst males. There was no increased risk of cerebrovascular disease.
Conclusions:
We have identified an increased risk of cardiovascular events and VTE, both prior to a diagnosis of SSc and within 8 years of SSc diagnosis. Work is needed to establish the mechanism of arterial/venous thrombotic events in SSc. This insight will facilitate more targeted and effective preventative strategies and improve outcomes in SSc.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis I: Introduction

